Article
Predicting Tumor Mutational Burden From Lung Adenocarcinoma Histopathological Images Using Deep Learning
8 Jun 2022
Abstract excerpt
Tumor mutation burden (TMB) is an important biomarker for tumor immunotherapy. It plays an important role in the clinical treatment process, but the gold standard measurement of TMB is based on whole exome sequencing (WES). WES cannot be done in most hospitals due to its high cost, long turnaround times and operational complexity. To seek out a better method to evaluate TMB, we divided the patients with lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
